External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder

European Urology

Volumn 61, Issue 1, 2012, Pages 58-64

  Nuhn, Philipp ^a   May, Matthias ^b   Sun, Maxine ^c   Fritsche, Hans Martin ^d   Brookman May, Sabine ^d   Buchner, Alexander ^a   Bolenz, Christian ^e   Moritz, Rudolf ^f   Herrmann, Edwin ^f   Burger, Maximilian ^d   Tilki, Derya ^a   Trojan, Lutz ^e   Perrotte, Paul ^c   Haferkamp, Axel ^g   Hohenfellner, Markus ^e   Wieland, Wolf F ^d   Müller, Stefan C ^h   Karakiewicz, Pierre I ^c   Bastian, Patrick J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Urologische Klinik   (Germany)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY OF BONN   (Germany)

Author keywords

Bladder cancer; Evaluation; Nomogram; Prediction; Prognosis; Radical cystectomy; Risk

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CALIBRATION; CANCER MORTALITY; CANCER RECURRENCE; CAUSE OF DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CAUSE OF DEATH; CYSTECTOMY; DISCRIMINANT ANALYSIS; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 82255175020     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.07.066     Document Type: Article

References (33)

1. A. Stenzl, N.C. Cowan, and M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
2. J. Nix, A. Smith, R. Kurpad, M.E. Nielsen, E.M. Wallen, and R.S. Pruthi Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results Eur Urol 57 2010 196 201
3. Challacombe BJ, Bochner BH, Dasgupta P, et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol. In press. DOI:10.1016/j.eururo.2011.05.012.
4. M.H. Hayn, N.J. Hellenthal, A. Hussain, A.P. Stegemann, and K.A. Guru Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology Eur Urol 59 2011 213 218
5. N. Lawrentschuk, R. Colombo, and O.W. Hakenberg Prevention and management of complications following radical cystectomy for bladder cancer Eur Urol 57 2010 983 1001
6. M. Maffezzini Re: urinary diversion and morbidity after radical cystectomy for bladder cancer Eur Urol 57 2010 1116
7. J.L. Gore, H.Y. Yu, C. Setodji, J.M. Hanley, M.S. Litwin, and C.S. Saigal Urinary diversion and morbidity after radical cystectomy for bladder cancer Cancer 116 2010 331 339
8. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium J Urol 176 2006 2414 2422 discussion 2422 (Pubitemid 44755069)
9. G. Dalbagni, E. Genega, and M. Hashibe Cystectomy for bladder cancer: a contemporary series J Urol 165 2001 1111 1116 (Pubitemid 32210214)
10. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675 (Pubitemid 32120143)
11. S. Madersbacher, W. Hochreiter, and F. Burkhard Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690 696 (Pubitemid 46621904)
12. G. Dalbagni, K. Vora, and M. Kaag Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer Eur Urol 56 2009 903 910
13. A.H. Feifer, J.M. Taylor, T.V. Tarin, and H.W. Herr Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy Eur Urol 59 2011 978 984
14. S.F. Shariat, V. Margulis, Y. Lotan, F. Montorsi, and P.I. Karakiewicz Nomograms for bladder cancer Eur Urol 54 2008 41 53
15. P.I. Karakiewicz, S.F. Shariat, and G.S. Palapattu Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder J Urol 176 2006 1354 1361 discussion 1361-2
16. B.H. Bochner, M.W. Kattan, and K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer J Clin Oncol 24 2006 3967 3972 (Pubitemid 46630745)
17. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu Nomograms provide improved accuracy for predicting survival after radical cystectomy Clin Cancer Res 12 2006 6663 6676 (Pubitemid 44876834)
18. E.W. Steyerberg, S.E. Bleeker, H.A. Moll, D.E. Grobbee, and K.G. Moons Internal and external validation of predictive models: a simulation study of bias and precision in small samples J Clin Epidemiol 56 2003 441 447 (Pubitemid 36694096)
19. A. Stenzl, N.C. Cowan, and M. De Santis The updated EAU guidelines on muscle-invasive and metastatic bladder cancer Eur Urol 55 2009 815 825
20. F. Harrell, K. Lee, and D. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
21. E. DeLong, D. DeLong, and D. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
22. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574 (Pubitemid 44728772)
23. H.W. Herr, J.R. Faulkner, and H.B. Grossman Surgical factors influence bladder cancer outcomes: a cooperative group report J Clin Oncol 22 2004 2781 2789 (Pubitemid 41079895)
24. A.S. Elstein Heuristics and biases: selected errors in clinical reasoning Acad Med 74 1999 791 794 (Pubitemid 29344140)
25. I. Vlaev, and N. Chater Game relativity: how context influences strategic decision making J Exp Psychol Learn Mem Cogn 32 2006 131 149 (Pubitemid 43283752)
26. M.W. Kattan Nomograms. Introduction Semin Urol Oncol 20 2002 79 81
27. R.M. Hogarth, and N. Karelaia Heuristic and linear models of judgment: matching rules and environments Psychol Rev 114 2007 733 758
28. D. Zaak, M. Burger, and W. Otto Predicting individual outcomes after radical cystectomy: an external validation of current nomograms BJU Int 106 2010 342 348
29. M. May, E. Herrmann, and C. Bolenz Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy Ann Surg Oncol 18 2011 2018 2025
30. M. May, E. Herrmann, and C. Bolenz Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy Eur Urol 59 2011 712 718
31. M.W. Kramer, R. Golshani, and A.S. Merseburger HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer Eur Urol 57 2010 86 94
32. S.F. Shariat, D.C. Chade, and P.I. Karakiewicz Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer J Urol 183 2010 68 75
33. S.F. Shariat, R.F. Youssef, and A. Gupta Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers J Urol 183 2010 1744 1750